Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 123.68
Day High 125.55
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest Press Releases

Global COVID-19 Diagnostics Market Size Worth USD 11.40 Billion at 7.9% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights(TM)
- GlobeNewswire - Tue Jan 19, 5:05AM CST
GlobeNewswire - CMTX
Tue Jan 19, 5:05AM CST
The global COVID-19 diagnostics market size is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights(TM) in its report. According to Johns Hopkins University, global COVID-19 infections reached 100,000 in just 60 days, growing to 200,000 in the next 12-14 days, and the recent addition of 100,000 cases has taken only 3 days. The calculation of the spread of this disease is based on the estimation of the "reproduction number" or R Naught (Ro).
Rev. Sharpton, Rev. Butts, U.S. Senator-Elect Rev. Warnock and over 100 Leading Black Clergy Convene on MLK Day to Confront COVID-19 in the Black Community
- PR Newswire - PRF - Mon Jan 18, 5:23PM CST
PR Newswire - PRF - CMTX
Mon Jan 18, 5:23PM CST
, /PRNewswire/ -- Today, on Day, a group of the nation's most renowned Black clergy led by Rev. and Rev. , III hosted the Choose Healthy Life Black Clergy Conclave. The event brought together over 100 of the nation's leading Black clergy who are stepping into the breach to address COVID-19's disproportionate impact on the Black community. The virtual conclave took place from .
Black and Hispanic/Latinx Americans Less Confident in Ability to Access COVID-19 Vaccines, Treatments and Healthcare than White Americans, Finds Quest Diagnostics Health Trends™ Analysis
- PR Newswire - PRF - Mon Jan 18, 6:34AM CST
PR Newswire - PRF - CMTX
Mon Jan 18, 6:34AM CST
, /PRNewswire/ -- A new Quest Diagnostics Health Trends™ study finds that Black and Hispanic/Latinx Americans are nearly two times as likely as White Americans to say their access to COVID-19 vaccines, treatments and healthcare, once available, is worse than other racial/ethnic groups.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 117.07 +6.86% increase
on 12/29/20
Period Open:120.23
Price movement based on the high, low and last over the given period.
127.71 -2.04% decrease
on 01/21/21
+4.87 (+4.05%) increase
since 12/24/20
3-Month 117.07 +6.86% increase
on 12/29/20
Period Open:124.32
Price movement based on the high, low and last over the given period.
129.21 -3.18% decrease
on 11/04/20
+0.78 (+0.63%) increase
since 10/26/20
52-Week 73.02 +71.32% increase
on 04/03/20
Period Open:107.79
Price movement based on the high, low and last over the given period.
131.81 -5.09% decrease
on 07/23/20
+17.31 (+16.06%) increase
since 01/24/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies